'Optical tweezers' help in quest for better cancer treatments

March 03, 2020

Stem cells involved in replenishing human tissues and blood depend on an enzyme known as telomerase to continue working throughout our lives. When telomerase malfunctions, it can lead to both cancer and premature aging conditions. Roughly 90% of cancer cells require inappropriate telomerase activity to survive.

In a groundbreaking new study, an interdisciplinary team of Michigan State University researchers has observed telomerase activity at a single-molecule level with unprecedented precision ¬¬¬¬- expanding our understanding of the vital enzyme and progressing toward better cancer treatments.

This breakthrough was made possible by a novel investigative procedure and a pair of "optical tweezers," designed in close collaboration by coauthors Jens Schmidt, assistant professor in the Department of Obstetrics, Gynecology and Reproductive Biology, and Matthew Comstock, assistant professor in the Department of Physics and Astronomy and the Jerry Cowen Endowed Chair of Experimental Physics.

Optical tweezers use powerful lasers to create small forces capable of pushing, pulling and holding microscopic objects like individual strands of DNA and a telomerase enzyme.

"Our optical tweezer method lets us take the little machines out of the cell, gently hold onto them and watch them go," Comstock said. "By watching the telomerase work in real time, we can learn how it functions in full detail."

We know that as stem cells divide over time, the chromosomes gradually decrease in length. Each chromosome end is capped by a telomere -- a disposable buffer of repeating DNA sequences.

The telomerase enzyme attaches to the telomere buffer and replaces most of the sequences lost during replication. It was thought that telomerase made progressive extensions in a single step, but scientists could only theorize as to how it stayed in contact and aligned with the right sequence.

What the researchers found was essentially a safety harness anchored to the chromosome in a seemingly specific location.

"In an ideal world we could inhibit telomerase in cancer cells without affecting stem cells," Schmidt said. "This anchor site is a potential drug target. If we or someone else finds a molecule that interferes with the telomerase anchor site, telomerase would fall off the chromosome end faster, stopping its activity."

The team hopes their method and discovery will help others in their research.

"It is very important that we also are showing other teams with optical tweezer instruments like ours how to do these experiments," Comstock said.

For Schmidt and Comstock, this discovery is the realization of a long-term goal - it sets the stage for a wide range of new research opportunities. And most importantly, brings us one step closer to more effective and safe cancer treatments.

Both Schmidt and Comstock emphasized the unique partnership between their respective laboratories, with key efforts in the lab from Research Associate Dr. Eric Patrick and undergraduate researchers Joseph Slivka and Bramyn Payne. The pair credit this close relationship as a key factor in the discovery.
-end-
The study, "Observation of processive telomerase catalysis using high-resolution optical tweezers," appears in Nature Chemical Biology.

(Note for media: Please include a link to the original paper in online coverage: https://www.nature.com/articles/s41589-020-0478-0)

Michigan State University has been working to advance the common good in uncommon ways for 160 years. One of the top research universities in the world, MSU focuses its vast resources on creating solutions to some of the world's most pressing challenges, while providing life-changing opportunities to a diverse and inclusive academic community through more than 200 programs of study in 17 degree-granting colleges.

For MSU news on the Web, go to MSUToday.

Michigan State University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.